See the DrugPatentWatch profile for cosentyx
What makes Cosentyx (secukinumab) “high risk”?
Cosentyx is not typically classed as a “high-risk” medicine in the same way some cancer drugs or strong immunosuppressants can be. It does, however, carry notable risks tied to its mechanism: it blocks IL-17A, which helps regulate immune responses. That means the main concerns are infections and other immune-related effects. [1]
Is the biggest risk infection?
Yes. Cosentyx can increase the risk of infections, particularly respiratory infections and other infections that can occur when parts of the immune system are suppressed. If an infection occurs, clinicians often reassess treatment and may hold or delay dosing until the infection resolves. [1]
Who might be considered higher risk when taking Cosentyx?
The risk profile can be higher in people with factors that increase baseline infection risk, such as:
- A history of recurrent or serious infections
- Ongoing or recent treatment with other immunosuppressive therapies (depending on the regimen)
- Comorbidities that affect immune function or overall health
Whether someone is “high risk” depends on their individual medical history and current medications, not just the drug name. [1]
What about “serious side effects” like hypersensitivity?
Serious allergic reactions are a known concern for many biologics, including Cosentyx. If someone develops signs of a serious allergy (for example, swelling of the face or throat, trouble breathing, or widespread rash), that’s an emergency and treatment should be stopped and addressed urgently. [1]
What patients usually ask: can it be used if I’m prone to infections?
Patients with frequent infections should have a risk-benefit discussion with their prescriber before starting. In practice, clinicians weigh disease severity (psoriasis/psoriatic arthritis/ankylosing spondylitis forms) against infection risk and may monitor more closely. [1]
How long is the risk a concern?
The infection and immune-related risks can be relevant throughout treatment, not only at the start, because the drug continues to affect immune signaling while it’s being given. If infections occur at any point, it can change how clinicians manage dosing. [1]
So is Cosentyx high risk overall?
Cosentyx is generally considered a controlled, prescription biologic with meaningful but manageable risks, with infection risk being the main safety issue to watch. For many people, it’s used routinely with appropriate screening and monitoring, but some patients may be higher risk based on their history and other medications. [1]
Sources
- https://www.cosentyx.com/safety-and-tolerability